An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection

NO_LONGER_AVAILABLE

Conditions studied: HIV Infection

In brief

This study is being conducted to assess the safety and tolerability of an oral liquid solution of Sustiva for antiretroviral therapy-naive or therapy-experienced HIV-1 infected children between the ages 3-16 who are failing or intolerant of current antiretroviral regimen and who are unable to swallow Sustiva capsules.

Key facts

Study ID
NCT00162227
Run by
Bristol-Myers Squibb
Starts
2000-09-01
Expected to finish
2010-12-01
Last updated by the study team
2014-01-09

Who can join

Age: 3 and older, up to 16. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.